arrow
Back
J

John F. Seymour

Peter MacCallum Cancer Centre

111H-index
995Paper Count
5.4WCitation Count
Published Papers 206
Publication Date
Comment on “EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation”
err2026-10-14
err0
errOAAI
errAlessandra Tedeschi; Raul Cordoba; Alessandra Ferrajoli; George Follows; Anna Maria Frustaci; Anne Sophie Michallet; Talha Munir; Susan O'Brien; John F. Seymour; Tait Shanafelt; Clemens Martin Wendtner; Pier Luigi Zinzani; Stephan Stilgenbauer
errShare
errSave
errShare
errSave
VEN-IBR in older and TP53-mt MCL: have sympathy for SYMPATICO
errBlood
IF23.1
err2026-09-17
err0
PREAI
errThomas E. Lew; John F. Seymour
errShare
errSave
Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel
err2026-09-08
err0
errOAAI
errBrydon Panozzo; Samuel Robinson; Adrian G. Minson; Jian Li; Kylie Baldwin; Hamish W. Scott; Jane Oliaro; Aaron J. N. Wong; Samantha van der Linde; Nicole L. O'Leary; Philip A. Thompson; John F. Seymour; Mary Ann Anderson; Constantine S. Tam; Simon J. Harrison; Michael J. Dickinson; David A. Westerman; Mark R. Dowling
errShare
errSave
Long-term outcomes with continuous venetoclax for relapsed chronic lymphocytic leukemia
err2026-07-28
err0
errOAAI
errSean McKeague; Thomas E. Lew; Anna Lowe; Leishong Lau; Philip A. Thompson; Ashley Whitechurch; Dennis Carney; Max Wolf; Gemma Reynolds; Piers Blombery; John F. Seymour; Andrew W. Roberts; Mary Ann Anderson
errShare
errSave
CRISPR in clinical oncology: translational advances from molecular diagnostics to therapeutics
err2026-07-09
err0
PREAI
errSamuel Grigg; Carolyn Shembrey; Mohamed Fareh; Piers Blombery; Jacob E. Corn; John F. Seymour; Joshua M. L. Casan
errShare
errSave
Impact of peri-transplant consolidative radiotherapy in patients with relapsed or refractory classical Hodgkin lymphoma
err2026-04-16
err0
errOAAI
errCampbell, Belinda A.; Minson, Adrian; Brown, Rachel J.; Chin, Collin K.; Wirth, Andrew; Hofman, Michael S.; MacManus, Michael; Seymour, John F.; Ritchie, David; Dickinson, Michael
errShare
errSave
Venetoclax Retreatment in Chronic Lymphocytic Leukemia is biologically rational and clinically effective
err2026-03-19
err0
errOAAI
errMathias Castonguay; Mary Ann Anderson; Philip Thompson; John F. Seymour
errShare
errSave
The Landscape and Evolution of Clonal Hematopoiesis in Chronic Lymphocytic Leukemia
errBlood
IF23.1
err2025-12-26
err0
errOAAI
errOthman Al-Sawaf; Benjamin N. Locher; Friederike Christen; Raphael Hablesreiter; Anantharamanan Rajamani; Sandra Robrecht; Can Zhang; Anna Maria Fink; Eugen Tausch; Christof Schneider; Matthias Ritgen; Karl Anton Kreuzer; Klara Kopp; Marie-Elisa Mertz; Coral Fustero-Torre; Karsten Kleo; John F. Seymour; Piers Blombery; Lars Bullinger; Brenda Chyla
errShare
errSave
Venetoclax and ibrutinib induces durable clinical responses in marginal zone lymphoma
err2025-12-15
err0
errOAAI
errSasanka M. Handunnetti; Amit Khot; Piers Blombery; Kate Burbury; Philip A. Thompson; David Ritchie; Rodney J. Hicks; Glenda Burke; Rachel Koldej; Mathias Bressel; Juliana Di Iulio; David A. Westerman; Stephen Lade; Andrew W. Roberts; John F. Seymour; Constantine S. Tam; Mary Ann Anderson
errShare
errSave
Epcoritamab, lenalidomide, and rituximab versus lenalidomide and rituximab for relapsed or refractory follicular lymphoma (EPCORE FL-1): a global, open-label, randomised, phase 3 trial
err2025-12-07
err0
errOAAI
errLorenzo Falchi; Marcel Nijland; Huiqiang Huang; Kim M Linton; John F Seymour; Rong Tao; Michal Kwiatek; Abel Costa; Theodoros P Vassilakopoulos; Richard Greil; Ana Jiménez-Ubieto; Shane A Gangatharan; Ohad Benjamini; Catherine Thieblemont; Alessandra Tucci; Anna Elinder-Camburn; Arpad Illes; Jan Novak; Miguel A Pavlovsky; Andrew McDonald
errShare
errSave
Beyond the CAR-T horizon in mantle cell lymphoma
err2025-11-11
err0
errOAAI
errThomas E. Lew; John F. Seymour
errShare
errSave
Expert consensus opinion on the management of hairy cell leukemia in elderly patients
err2025-10-01
err0
PREAI
errTadmor, Tamar; Demeter, Judit; Fagarasanu, Andrei; Kreitman, Robert J.; Parikh, Sameer A.; Ravandi, Farhad; Rogers, Kerry A.; Saven, Alan; Seymour, John F.; Tam, Constantine S.; Tallman, Martin S.; Tiacci, Enrico; Zenz, Thorsten; Zent, Clive S.; Wormann, Bernhard; Grever, Michael R.; Yurkovski, Ilana Levy
errShare
errSave
Clinical outcomes with venetoclax-based therapy in patients with relapsed/refractory B-cell lymphomas
err2025-10-01
err0
PREAI
errFasser, Daniel; Joy, Greta; Dowling, Mark R.; Bavishi, Ketan; Ovlisen, Andreas Kiesbye; Choi, Philip; P'ng, Stephanie; Filshie, Robin; Ritchie, David; Bilmon, Ian; Prince, H. Miles; Wolf, Max; Hertzberg, Mark; Chuah, Hun; El-Galaly, Tarec; Tam, Constantine; Seymour, John; Villa, Diego; Cheah, Chan Y.; Lewis, Katharine L.
errShare
errSave
Landscape of TP53 abnormalities and IGHV mutational profile in untreated Australian patients with chronic lymphocytic leukaemia
err2025-09-05
err0
PREAI
errSally M. Hunter; Lana Radulovic; Ella R. Thompson; Michelle McBean; John F. Seymour; David Westerman; Piers Blombery
errShare
errSave
Resistance to targeted therapies in chronic lymphocytic leukemia: Current status and perspectives for clinical and diagnostic practice
errLeukemia
IF13.4
err2025-06-24
err0
errOAAI
errPiers Blombery; Thomas Chatzikonstantinou; Marina Gerousi; Richard Rosenquist; Gianluca Gaidano; Sarka Pospisilova; Andrew W. Roberts; Richard W. Birkinshaw; Davide Rossi; Lydia Scarfo; John F. Seymour; Stephan Stilgenbauer; Adrian Wiestner; Jennifer A. Woyach; Jennifer R. Brown; Paolo Ghia; Kostas Stamatopoulos
errShare
errSave
Emergent BAX-mutated clonal hematopoiesis after venetoclax-based therapy for breast cancer
err2025-05-30
err0
errOAAI
errIng S. Tiong; Tamia Nguyen; Chong C. Chua; Charis E. Teh; Christine Muttiah; Sarah Ftouni; John F. Seymour; Daniel Gray; Andrew W. Roberts; Sarah-Jane Dawson; Geoffrey J. Lindeman; Piers Blombery
errShare
errSave
Beyond maximum grade: introduction to The Lancet Haematology Adverse Events Reporting Series
err2025-05-28
err0
PREAI
errGita Thanarajasingam; Ajay Major; Vishal Bhatnagar; Amylou C Dueck; Karin E Smedby; Tarec Christoffer El-Galaly; Jan Geissler; Thomas Habermann; Paul G Kluetz; John F Seymour; Kyriaki Tzogani; Diego Villa; Paul J Bröckelmann
errShare
errSave
Report of Consensus Panel 4 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with non-IgM lymphoplasmacytic lymphoma
err2025-04-08
err0
PREAI
errAlessandra Tedeschi; Rebecca Auer; Francesco Autore; Jorge J. Castillo; Moshe E. Gatt; Eva Kimby; David F. Moreno; Roger G. Owen; Lugui Qiu; Aldo M. Roccaro; Shayna Sarosiek; Naohiro Sekiguchi; John F. Seymour; Marzia Varettoni; Christopher J. Patterson; Jeffrey V. Matous; Christian Buske; Steven P. Treon; Ramon Garcia Sanz
errShare
errSave
Report of Consensus Panel 5 from the 12th International Workshop on Waldenstrom's Macroglobulinemia on the management of patients with intolerance or resistance to covalent BTK inhibitors
err2025-04-08
err0
PREAI
errJorge J. Castillo; Francesco Autore; Neil L. Berinstein; Andrew R. Branagan; Meletios A. Dimopoulos; Carlos Fernandez de Larrea; Simone Ferrero; Prashant Kapoor; Efstathios Kastritis; Jahanzaib Khwaja; Monique C. Minnema; Lugui Qiu; John F. Seymour; Josephine M.I. Vos; Christopher J. Patterson; Christian Buske; Jeffrey V. Matous; Steven P. Treon; M. Lia Palomba
errShare
errSave